Tiziana Life Sciences Ltd Research and Development Expense
Tiziana Life Sciences Ltd (TLSA) reported Research and Development Expense of $5.23 million for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-05-08.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-05-08
| Period end | Research And Development Expense 12 month |
|---|---|
| 2024-12-31 | $5.23M 20-F/A · filed 2025-05-08 |
| 2023-12-31 | $8.11M 20-F/A · filed 2025-05-08 |
| 2022-12-31 | $12.96M 20-F/A · filed 2025-05-08 |
| 2021-12-31 | $13.21M 20-F · filed 2024-05-10 |
| 2020-12-31 | $5.99M 20-F/A · filed 2023-06-13 |
| 2019-12-31 | $3.71M 20-F · filed 2022-05-23 |
| 2018-12-31 | $5.51M 20-F · filed 2021-05-17 |
| 2017-12-31 | $6.01M 20-F · filed 2020-06-17 |
| 2016-12-31 | $4.01M 20-F · filed 2019-04-04 |